Tara Holder
Cardiovascular Disease · Greenville, SCNPI 1588027254
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Regeneron at 34.2% of the total. 2025 is the largest year on record at $8,290, more than ten times the $254 reported in 2021. Among cardiovascular disease clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 254 payments — averaging $79.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$7K
- Abbott$4K
- Medtronic$3K
- Boston Scientific$1K
- Cardiovascular Systems Inc.$1K
- Shockwave Medical, Inc$872
- plus $3K from 29 others
What the payments were for
- Consulting fees$5,38727%
- Travel & lodging$5,30126%
- Food & beverage$9,26846%
- Education$2731%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 13 | $6,926 |
| Abbott | 59 | $3,679 |
| Medtronic | 31 | $3,203 |
| Boston Scientific | 15 | $1,164 |
| Cardiovascular Systems Inc. | 7 | $1,094 |
| Shockwave Medical, Inc | 20 | $872 |
| Philips North America LLC | 10 | $428 |
| Novartis | 23 | $376 |
| Amgen | 8 | $341 |
| Inari Medical, Inc. | 2 | $336 |
| Angiodynamics, Inc. | 4 | $281 |
| Penumbra, Inc. | 8 | $249 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $220 |
| Abiomed | 6 | $145 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $123 |
| Johnson & Johnson | 6 | $96 |
| AstraZeneca | 6 | $95 |
| E.r. Squibb & Sons, L.L.C. | 5 | $81 |
| Surmodics, Inc. | 1 | $61 |
| Boehringer Ingelheim | 3 | $53 |
| Terumo Medical Corporation | 3 | $53 |
| Kestra Medical Technology Services, Inc. | 2 | $47 |
| Teleflex LLC | 1 | $37 |
| Cagent Vascular Inc | 1 | $37 |
| Actelion Pharmaceuticals US, Inc. | 1 | $34 |
| Reflow Medical Inc | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
| Chiesi USA, Inc. | 1 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $19 |
| Pfizer | 1 | $18 |
| Merck | 1 | $18 |
| Atricure, Inc. | 1 | $16 |
| Bard Peripheral Vascular, Inc. | 1 | $15 |
| Cordis US CORP. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUPERA$1,636
- Diamondback Peripheral$998
- VenaSeal$987
- RESOLUTE ONYX$825
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$340
- FLOWTRIEVER CATHETER, S$336
- CT THROMBECTOMY SYSTEM KIT$336
- ACCULINK$312
- AlphaVac$244
- OPTICROSS$243
- CARDIOMEMS$202
- AVVIGO Guidance System$180
- ONYX FRONTIER$166
- Diamondback Coronary$156
- XACT$150
- WATCHMAN FLX$145
- Resolute$142
- JETi Peripheral Catheter$142
- ARCALYST$123
- SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY$122
How this compares
$20,229 in reported general payments places this provider in the 90th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $108,293 |
| XareltoRivaroxaban | 58 | $69,856 |
| Repatha SureclickEvolocumab | 59 | $61,043 |
| JardianceEmpagliflozin | 45 | $55,841 |
| EntrestoSacubitril/Valsartan | 16 | $26,204 |
| Rosuvastatin Calcium | 235 | $3,823 |
| Metoprolol Succinate | 207 | $2,698 |
| Atorvastatin Calcium | 128 | $1,469 |
| ClopidogrelClopidogrel Bisulfate | 88 | $1,337 |
| Ezetimibe | 48 | $883 |
| Losartan Potassium | 74 | $829 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 51 | $796 |
| Ranolazine ErRanolazine | 13 | $615 |
| Ramipril | 14 | $537 |
| Amlodipine Besylate | 86 | $473 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $18 | $108,29381 claims |
| Johnson & JohnsonXarelto | $96 | $69,85658 claims |
| Boehringer IngelheimJardiance | $53 | $55,84145 claims |
| NovartisEntresto | $376 | $26,20416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 257 cardiovascular disease providers in South Carolina.
Other cardiovascular disease in Greenville
- Gregory SanGreenville$88K
- David McNeelyGreenville$78K
- Christopher SalmonGreenville$54K
- Arthur EberlyGreenville$34K
- Dev VazGreenville$14K
- Jon BittrickGreenville$13K
- James MerriamGreenville$11K
- Harold BlanksGreenville$9K
- Arthur SiachosGreenville$9K
- Robert BiedermanCharleston$775K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.